Nirma gets CCI for acquisition of majority stake in Glenmark Life Sciences

In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS to Nirma Ltd for Rs 5,651.5 crore.

Related Keywords

India , ,Nirma Ltd For Rs ,Glenmark Life Sciences Ltd ,Glenmark Life Sciences ,Competition Commission Of India ,Nirma Ltd ,Glenmark Pharmaceuticals ,Ahmedabad Based Nirma ,Competition Commission ,Glenmark Life Sciences Limited ,Life Sciences Ltd ,Active Pharmaceutical Ingredients ,Nirma ,